Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Serum Institute of India Pvt. Ltd., a biotechnology company that develops and manufactures vaccines for diphtheria, tetanus, pertussis, Hib, BCG, r-hepatitis B, measles, mumps, and rubella disease.
Serum Institute Of India Private Limited, is an unlisted private company incorporated on 22 May, 1984. It is classified as a private limited company and is located in Pune, Maharashtra. It's authorized share capital is INR 55.00 cr and the total paid-up capital is INR 4.82 cr.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | 5,446.0 | 7,201.0 | 25,645.0 | 10,190.0 | 9,549.0 |
Operating profit | 2,767.0 | 4,247.0 | 17,445.0 | 5,630.0 | 4,516.0 |
Net profit | 2,251.0 | 3,891.0 | 11,116.0 | 4,187.0 | 4,278.0 |
Gross margin | 87.4 | 94.4 | 84.9 | 88.4 | 86.8 |
Operating margin | 50.8 | 59.0 | 68.0 | 55.2 | 47.3 |
Net margin | 38.1 | 46.7 | 41.6 | 39.0 | 38.6 |
Networth | 17,929.0 | 21,839.0 | 32,933.0 | 36,902.0 | 41,187.0 |
Borrowings | 49.0 | 196.0 | 191.0 | 57.0 | 302.0 |
Assets | 18,873.0 | 26,446.0 | 37,133.0 | 40,049.0 | 44,654.0 |
Debt to equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Current ratio | 5.1 | 1.9 | 2.0 | 3.7 | 4.0 |
ROE | 12.6 | 17.8 | 33.8 | 11.3 | 10.4 |
Days payable | 96.0 | 354.0 | 56.0 | 167.0 | 235.0 |
WC days | 225.0 | 188.0 | 51.0 | 233.0 | 314.0 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | 4.8 | 4.8 | 4.8 | 4.8 | 4.8 |
Reserves | 17,924.2 | 21,834.2 | 32,928.2 | 36,897.2 | 41,182.2 |
Borrowings + | 49.0 | 196.0 | 191.0 | 57.0 | 302.0 |
Long term borrowings | - | - | - | - | - |
Short term borrowings | 49.0 | 196.0 | 191.0 | 57.0 | 302.0 |
Trade payables + | 180.0 | 391.0 | 591.0 | 540.0 | 812.0 |
Days payable | 96.0 | 354.0 | 56.0 | 167.0 | 235.0 |
Other liabilities + | 895.0 | 4,411.0 | 4,009.0 | 3,090.0 | 3,165.0 |
Other non-current liabilities | 132.0 | 456.0 | 535.0 | 714.0 | 691.0 |
Other current liabilities | 583.0 | 3,564.0 | 2,883.0 | 1,836.0 | 1,662.0 |
Total liabilities | 18,873.0 | 26,446.0 | 37,133.0 | 40,049.0 | 44,654.0 |
Fixed Assets + | 3,398.0 | 4,730.0 | 4,754.0 | 6,114.0 | 9,029.0 |
Tangible assets | 1,519.0 | 1,991.0 | 2,279.0 | 2,174.0 | 1,967.0 |
CWIP | 1,643.0 | 2,539.0 | 2,348.0 | 3,853.0 | 6,869.0 |
Intangible assets | 236.0 | 200.0 | 127.0 | 87.0 | 193.0 |
LT loans and advances | 367.0 | 226.0 | 68.0 | 331.0 | 211.0 |
Other non-current assets | 10,944.0 | 13,627.0 | 25,054.0 | 24,679.0 | 24,421.0 |
Current assets + | 4,164.0 | 7,863.0 | 7,257.0 | 8,925.0 | 10,993.0 |
Inventories | 1,714.0 | 2,855.0 | 2,618.0 | 3,735.0 | 4,505.0 |
Trade receivables | 1,134.0 | 2,205.0 | 2,725.0 | 3,079.0 | 2,124.0 |
Cash and cash equivalents | 321.0 | 1,757.0 | 953.0 | 733.0 | 1,072.0 |
ST loans and advances | - | 58.0 | - | 328.0 | 178.0 |
Other current assets | 995.0 | 988.0 | 961.0 | 1,050.0 | 3,114.0 |
Total assets | 18,873.0 | 26,446.0 | 37,133.0 | 40,049.0 | 44,654.0 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales + | 5,446.0 | 7,201.0 | 25,645.0 | 10,190.0 | 9,549.0 |
Sales growth % | 3.97 | 32.23 | 256.13 | -60.27 | -6.29 |
Expenses + | 2,972.0 | 3,427.0 | 9,779.0 | 5,404.0 | 5,658.0 |
Cost of goods | 684.0 | 403.0 | 3,878.0 | 1,181.0 | 1,261.0 |
Employee cost | 853.0 | 1,350.0 | 1,917.0 | 1,368.0 | 1,458.0 |
Other costs | 1,142.0 | 1,201.0 | 2,405.0 | 2,011.0 | 2,314.0 |
Operating profit + | 2,767.0 | 4,247.0 | 17,445.0 | 5,630.0 | 4,516.0 |
Operating margin % | 50.8 | 59.0 | 68.0 | 55.2 | 47.3 |
Other income | 460.0 | 1,134.0 | 1,073.0 | 543.0 | 1,527.0 |
Interest | 26.0 | 43.0 | 70.0 | 64.0 | 65.0 |
Depreciation | 267.0 | 430.0 | 1,509.0 | 780.0 | 560.0 |
Exceptional items | - | - | - | - | - |
Profit before tax | 2,934.0 | 4,908.0 | 16,939.0 | 5,329.0 | 5,418.0 |
Tax | 683.0 | 1,017.0 | 5,823.0 | 1,142.0 | 1,140.0 |
Profit - disc. ops | - | - | - | - | - |
Net profit | 2,251.0 | 3,891.0 | 11,116.0 | 4,187.0 | 4,278.0 |
Net margin % | 38.1 | 46.7 | 41.6 | 39.0 | 38.6 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Debt/Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Debt/Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Assets/Equity | 1.1 | 1.2 | 1.1 | 1.1 | 1.1 |
Liquidity + | |||||
Current Ratio | 5.1 | 1.9 | 2.0 | 3.7 | 4.0 |
Quick Ratio | 3.0 | 1.2 | 1.3 | 2.1 | 2.3 |
Interest Coverage | 106.4 | 98.8 | 249.2 | 88.0 | 69.5 |
Performance | |||||
Gross Margin | 87.4 | 94.4 | 84.9 | 88.4 | 86.8 |
Operating Margin | 50.8 | 59.0 | 68.0 | 55.2 | 47.3 |
Net Margin | 38.1 | 46.7 | 41.6 | 39.0 | 38.6 |
Return + | |||||
Return on Equity | 12.6 | 17.8 | 33.8 | 11.3 | 10.4 |
Pre-tax ROCE | 37.0 | 45.2 | 190.9 | 38.5 | 22.9 |
Return on Assets | 11.9 | 14.7 | 29.9 | 10.4 | 9.6 |
Pre-tax ROIC | 13.9 | 17.5 | 48.4 | 13.1 | 9.6 |
Efficiency + | |||||
Days Payable | 96.0 | 354.0 | 56.0 | 167.0 | 235.0 |
Days Inventory | 915.0 | 2,586.0 | 246.0 | 1,154.0 | 1,304.0 |
Days Receivable | 76.0 | 112.0 | 39.0 | 110.0 | 81.0 |
Fixed Asset Turnover | 1.6 | 1.5 | 5.4 | 1.7 | 1.1 |
Total Asset Turnover | 0.3 | 0.3 | 0.7 | 0.2 | 0.2 |
Working Capital | |||||
Cash Conversion Cycle | 895.0 | 2,344.0 | 229.0 | 1,097.0 | 1,150.0 |
Working Capital Days | 225.0 | 188.0 | 51.0 | 233.0 | 314.0 |
AMBIT CAPITAL PRIVATE LIMITED
No. of Loans: 1
Total Amount : 10.0 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Managing Director | Cyrus Soli Poonawalla
Shareholder
|
00044650 | 18 years |
Director | Zavareh Soli Poonawalla
Shareholder
|
00044760 | 41 years |
Whole-time Director | Adar Cyrus Poonawalla
Shareholder
|
00044815 | 17 years |
Kmp | Adar Cyrus Poonawalla | <HIDDEN> | 11 years |
Director | Behroze Zavareh Poonawalla | 00044877 | 39 years |
Whole-time Director | Umesh Sharadrao Shaligram | 00212458 | 4 years |
Whole-time Director | Satish Ramchandra Mundra | 00416654 | 15 years |
Whole-time Director | Natasha Adar Poonawalla | 01264082 | 9 years |
Kmp | Sunder Lata Anand Kavitkar | <HIDDEN> | 2 years |
Director | Parag Rajendra Deshmukh | 03377341 | 1 years |
Whole-time Director | Kedar Shashikant Gokhale | 08788551 | 3 years |
Whole-time Director | Sunil Gairola | 08893242 | 4 years |
Whole-time Director | Prasad Suryakant Kulkarni | 08991838 | 4 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
SOVEREIGN PHARMA PRIVATE LIMITED |
Active
|
98.0 Cr | 2 | Maharashtra |
ADRUS ESTATES AND PROPERTIES PVT LTD |
Converted to LLP and Dissolved
|
1.0 L | 1 | Maharashtra |
VILLOO POONAWALLA RACING & BREEDING PRIVATE LIMITED |
Active
|
44.0 Cr | 3 | Maharashtra |
GENESIS PARKS LLP |
Active
|
5.0 Cr | 2 | Maharashtra |
ADAR ESTATES LLP |
Active
|
5.0 Cr | 2 | Maharashtra |
POONAWALLA AVIATION PRIVATE LIMITED |
Active
|
1,410.3 Cr | 1 | Maharashtra |
POONAWALLA INVESTMENTS AND INDUSTRIES PRIVATE LIMITED |
Active
|
98.6 L | 2 | Maharashtra |
POONAWALLA ESTATES STUD AND AGRI FARM PRIVAE LIMITED |
Active
|
41.4 Cr | 2 | Maharashtra |
SERUM INTERNATIONAL LIMITED |
Amalgamated
|
4.1 Cr | 4 | Maharashtra |
THE POONA STUD FARM PRIVATE LIMITED |
Active
|
1.6 Cr | 2 | Maharashtra |
POONAWALLA ASTONISH STUD PRIVATE LIMITED |
Active
|
5.6 Cr | 2 | Maharashtra |
ASTONISH STUD PRIVATE LIMITED |
Amalgamated
|
24.3 L | 2 | Maharashtra |
SHELLAC TRADING PRIVATE LIMITED |
Strike Off
|
1,000.0 | 1 | Maharashtra |
ANNILNA INVESTMENT PVT LTD |
Active
|
28.0 L | 2 | Maharashtra |
SIMONE POONAWALLA CONSTRUCTIONS AND STUD PRIVATE LIMITED |
Active
|
20.3 L | 1 | Maharashtra |
INTERVALVE POONAWALLA LIMITED |
Active
|
8.8 Cr | 1 | Maharashtra |
YODELSIM HOLDINGS PVT. LTD. |
Active
|
88.5 L | 2 | Maharashtra |
SASWAD INVESTMENT PVT LTD |
Amalgamated
|
99.8 L | 1 | Maharashtra |
POONAWALLA FINVEST AND AGRO PRIVATE LIMITED |
Active
|
87.0 L | 2 | Maharashtra |
POONAWALLA FINANCIALS PRIVATE LIMITED |
Active
|
20.9 Cr | 2 | Maharashtra |
EL-O-MATIC (INDIA) PRIVATE LIMITED |
Active
|
96.8 L | 1 | Maharashtra |
CARTIER INVESTMENT PRIVATE LIMITED |
Active
|
3.5 Cr | 1 | Maharashtra |
DELNA PROPERTIES PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 2 | Maharashtra |
POONAWALLA RACING AND BREEDING PRIVATE LIMITED |
Active
|
10.0 L | 2 | Maharashtra |
POONAWALLA HOTELS PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 1 | Maharashtra |
YOHAN POONAWALLA FINANCIALS PRIVATE LIMI TED |
Amalgamated
|
1.1 Cr | 2 | Maharashtra |
POONAWALLA EXHILARATION STUD PRIVATE LIMITED |
Active
|
5.0 L | 2 | Maharashtra |
POONAWALLA MYSTICAL STUD PRIVATE LIMITED |
Active
|
5.0 L | 2 | Maharashtra |
POONAWALLA CONSTRUCTIONS PRIVATE LIMITED |
Converted to LLP and Dissolved
|
18.4 Cr | 1 | Maharashtra |
EXHILARATION STUD PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 2 | Maharashtra |
POONAWALLA REAL ESTATES AND HOTELS LLP |
Active
|
18.6 Cr | 1 | Maharashtra |
SIMONE POONAWALLA PROJECTS LLP |
Active
|
10.0 L | 2 | Maharashtra |
DELNA POONAWALLA PROJECTS LLP |
Active
|
10.0 L | 2 | Maharashtra |
DELNA PROPERTIES LLP |
Active
|
1.0 L | 2 | Maharashtra |
CYZA AGRO AND STUD FARMS LLP |
Active
|
24.9 L | 1 | Maharashtra |
POONAWALLA CONSTRUCTIONS LLP |
Active
|
18.4 Cr | 2 | Maharashtra |
CARTIER PROPERTIES LLP |
Active
|
3.5 Cr | 1 | Maharashtra |
POONAWALLA HOLDINGS LLP |
Active
|
1.4 Cr | 2 | Maharashtra |
SHELLAC PROPERTIES LLP |
Active
|
95.5 L | 1 | Maharashtra |
YOHAN POONAWALLA PROJECTS LLP |
Active
|
10.0 L | 2 | Maharashtra |
POONAWALLA STUD FARM PRIVATE LIMITED |
Active
|
5.4 L | 1 | Maharashtra |
CYZA AGRO AND STUD FARMS PRIVATE LIMITED |
Converted to LLP and Dissolved
|
24.9 L | 2 | Maharashtra |
INTERVALVE POONAWALLA LIMITED |
Active
|
8.8 Cr | 1 | Maharashtra |
SANOTI PROPERTIES LLP |
Active
|
10.0 Cr | 1 | Maharashtra |
SERUM INSTITUTE LIFE SCIENCES PRIVATE LIMITED |
Active
|
636.6 Cr | 6 | Maharashtra |
RISING SUN HOLDINGS PVT LTD |
Active
|
7,794.0 Cr | 1 | Maharashtra |
POONAWALLA FINCORP LIMITED |
Active
|
155.5 Cr | 1 | Maharashtra |
POONAWALLA FINANCE PRIVATE LIMITED |
Active
|
1,230.6 Cr | 1 | Maharashtra |
POONAWALLA CREDIT PRIVATE LIMITED |
Active
|
254.9 Cr | 1 | Maharashtra |
COVIDSHIELD TECHNOLOGIES PRIVATE LIMITED |
Active
|
7.5 Cr | 1 | Maharashtra |
AMRON REALTORS PRIVATE LIMITED |
Active
|
107.5 Cr | 1 | Maharashtra |
SRI THAKUR BIOTECH LLP |
Active
|
50,000.0 | 1 | Maharashtra |
PHINITY DEVELOPERS PRIVATE LIMITED |
Active
|
1,061.0 Cr | 1 | Maharashtra |
KEDAR GOKHALE ADVISORY LLP |
Active
|
5,000.0 | 1 | Maharashtra |
GAIROLA BIOTECH ADVISORY LLP |
Active
|
1.0 L | 1 | Maharashtra |
PAURAS ADVISORY LLP |
Active
|
50,000.0 | 1 | Maharashtra |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
SERUM INTERNATIONAL B.V. | Netherlands | - | - |
Bilthoven Biologicals B.V. | Netherlands | - | - |
SERUM INSTITUTE INC | United States | - | - |
Serum Life Science Europe Gmbh | Germany | - | - |
SEZ BIOTECH SERVICES PRIVATE LIMITED | Maharashtra | 2006 | ₹ 1,250.4 Cr |
POONAWALLA AVIATION PRIVATE LIMITED | Maharashtra | 2005 | ₹ 1,410.3 Cr |
Serum Life Sciences B.V | Netherlands | - | - |
Serum AMR Products B.V. | Netherlands | - | - |
SERUM INSTITUTE LIFE SCIENCES PRIVATE LIMITED | Maharashtra | 2020 | ₹ 636.6 Cr |
Serum Life Sciences Ltd | United Kingdom | - | - |
COVIDSHIELD TECHNOLOGIES PRIVATE LIMITED | Maharashtra | 2019 | ₹ 7.5 Cr |
SERUM INSTITUTE VACCINES PRIVATE LIMITED | Maharashtra | 2021 | ₹ 113.3 Cr |
SERUM LIFECARE FOUNDATION | Maharashtra | 2023 | ₹ 0.0 |
Serum Global FZCO | United Arab Emirates | - | - |
Serum Middle East Holdings FZCO | United Arab Emirates | - | - |
Diamond Worldwide Finance Ltd | United Kingdom | - | - |
The incorporation date of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is 22 May, 1984
The authorized share capital of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is INR ₹ 55.0 Cr.
The paid-up capital of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is INR ₹ 4.8 Cr.
The registered address of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is 212/2 OFF SOLI POONAWALLA ROAD, HADAPSAR PUNE Pune Maharashtra - 411028
The CIN number of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is U80903PN1984PTC032945.